{"type":"rich","title":"Episode 78: Regulatory and Commercial Considerations for Hemp-Derived CBD","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"Cannabis Tech Talks","html":"<iframe src=\"https://player.blubrry.com/?media_url=https%3A%2F%2Fmedia.blubrry.com%2Fcannabistechtalks%2Fcontent.blubrry.com%2Fcannabistechtalks%2Fctt078.mp3\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"How do cannabis chemotypes shape market access? What\u2019s the FDA\u2019s position on CBD as a consumer product ingredient? Listen in as Dr. Duffy MacKay shares what he\u2019s learned as the senior vice president o","thumbnail_url":"https://cannabistechtalks.blubrry.net/wp-content/uploads/powerpress/CannaTechTalks_ICON_copy-184.jpg"}